is retatrutide a glp-1 drug who makes Demand for Unapproved Weight-Loss Surges on Social Media Retatrutide: 24% Weight Loss Without
Description
Lancet 381 , 117124 (2013)

This is of importance, as patients on GLP-1 Agonists represent a specific subset with impaired gastric emptying such that water is recommended as the only liquid from 6 hours pre-induction, with patients nil by mouth for the final 2 hours
References American Diabetes Association Professional Practice Committee

Rubino D, STEP 4 Investigators, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA et al

For researchers currently using retatrutide, the best approach is informed engagement

Mevcut bilimsel veriler nda GLP-1 ilalarnn hamilelikte kullanm nerilmez
